A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Dengue is a rapidly emerging, mosquito-borne viral infection, with an estimated 400 million infections occurring annually. To gain insight into dengue immunity, we characterized 145 human monoclonal antibodies (mAbs) and identified a previously unknown epitope, the envelope dimer epitope (EDE), that...
Uložené v:
| Hlavný autor: | |
|---|---|
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
2018
|
| On-line prístup: | https://demo7.dspace.org/handle/123456789/219 |
| Tagy: |
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
Podobné jednotky: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus
- Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- Dengue Virus Infections and Maternal Antibody Decay in a Prospective Birth Cohort Study of Vietnamese Infants
- Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections
- Comparative Susceptibility of Aedes albopictus and Aedes aegypti to Dengue Virus Infection After Feeding on Blood of Viremic Humans: Implications for Public Health